{"id":934480,"date":"2026-02-05T08:36:31","date_gmt":"2026-02-05T13:36:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/"},"modified":"2026-02-05T08:36:31","modified_gmt":"2026-02-05T13:36:31","slug":"boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","title":{"rendered":"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Feb.  05, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hWYhqqRH-rLyJiBcZEvDON81Q9WpClGi09qQkA8AknbhjR97b_qiicWBujTq0bklH8At1CflhFPT-z-lgAUSiSK1DCXvEQqLCSilfalW8EI=\" rel=\"nofollow\" target=\"_blank\">Boundless Bio<\/a> (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026.<\/p>\n<p align=\"justify\">The fireside chat session is scheduled for Thursday, February 12, in New York, NY, at 3:00 p.m. ET. A live and archived webcast of the session will be accessible under \u201cEvents &amp; Presentations\u201d in the Investors section of Boundless Bio\u2019s website.<\/p>\n<p>\n        <strong>About Boundless Bio<\/strong>\n      <\/p>\n<p align=\"justify\">Boundless Bio\u00a0is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors. Boundless Bio\u2019s research focuses on extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in 14% to 17% of cancer patients.\u00a0Boundless Bio\u00a0is developing BBI-940, a potentially first-in-class orally bioavailable, selective Kinesin degrader as an ecDNA-directed therapeutic candidate (ecDTx).\u00a0Boundless Bio\u00a0is headquartered in\u00a0San Diego, CA.<\/p>\n<p align=\"justify\">For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oA3y3yEkBqyL2HC0quKtAFaSBus0qVIoDwzDMpUW6pz8hwPUed97CZAr-NdYosOnG_YPKkVQUaFpTPCYy8DYqp1l-GhAQ8VaPE8RyJ2-mj8RHZGHITt_tx1eVdcLKjarUioMrEOOYMCXOlpQXIGcxJKcmdxRNdJgdr9K7s_X_oJDLcafluZ1KEkzySFuHfFbSA8O3O8w2TABseFmjc1keikk3d0vWL1onrcfIpO5cnLdEUxVLZkvaBdQrxK7kqpFA7YhmxO42EuO3TQYUaOJd_MVvYbS9sTxt222_6zlOaEkpn7YsjhZl6yM3SrmDh6zxgH-JG4uYxvRpn9SDsCJwdd1EY3gqJ0pfBQh5HmWZ3HMoaijX66wh7-dWHftyu8xpGuYrKmoYpqatBxcGg9rz5Pf60N1pqU68ZOZCNzo-IYaOlsKuKsJIbPxz5c2FlySjI77svlMGyBjUZOZrOAHU6Q1fwvAd477EsOmXxYLFzYBvXJV5KcggCAyq_zYClDL\" rel=\"nofollow\" target=\"_blank\">www.boundlessbio.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TMZu70rodRUGM107ybqiJkMZMXoP3U3NPUP5dYh8BCXowciVV_zHKJcQFDOvlPkcOfZOqWtDorT-f5yt2ShIaIEh4Wa6yUB4RE2pIp-a7pU8VvbbMIrS3i72Gqye6FUxY2ZgacEChibkvfWAQGvOD4amgYtz27v0pAbx6fDvC8YVLGlCllvuXOQWPGm7ijlHrvdgU55FsfEPs5XTF3IrpPsFAXRaEwr3dQsNLAIjhhLvBxD23p2_IwZMav4e5flgMX7amum1AY693aFrJGD9grh_BfS-hXO4CPisFLhinCc_dSZ0FGTrnaeljajUgbfZHwyXuPXuDcUlZ_Z2vXlAmOuLDUXMV5mL066OX7yzbJAg6ptf-_Ck2YWtZw1bgJDI4-Vnf70P8a8MP6V1ZILT0EtZFI3kGNh5ogiFIET0fNCLlUlQPIZ1ijMaHtGpdf91fBXoconjTmytH1BXb8ptY2lhsdrteKqmxtOz7oq7YgM=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7_IHaAm8t0_naDv6frbZd99dPW7-IZtlAeXtvQYagi5qSHtDay4pZGgFs0FIOxDTKi_Mim3uwf1pZjbnL4JrvBjkKuKrYWBWgMqeu6uC3ii24ltKf4aIU2PBlYYdAtMclGB0SawE6scDsUr5UI028e3PcNdIMYFF7VBEjxBJuCJxdKEJtlprIpKv7KESKcVC2cCu2VlQaIEOQqC45GLWBguAd_JOyZHnbZo7oNQtS_lVqoplJf5hpflIg4a9EMcWtsIT5dDobX_AZxtAgLgiPpqr9LQyWAEy20r27XtwftOdaaaTlsM-0cWRwPPEw2IQGZiIjgFzBetwQEXwznV99bsn1aj0pFTcjbFcXYeUMOn9qLUGbeALp979HoQBdCCc\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Contacts: <\/strong><br \/>\n        <br \/>James Lee, Boundless Bio<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vR8aidmQJyHUBTIzqc59aExwHJaTMpjFnW_onOPn9VWMuSV3Yvaq0YHvbEz7RY6O3Km5QIlw-7TM4ALgCBBS3q_AJZyzhQDDwFKUSUQDfCc=\" rel=\"nofollow\" target=\"_blank\">jlee@boundlessbio.com<\/a><\/p>\n<p>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Renee Leck<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0TR20_WcVEOWCVm2LFxNfrFn9Cks3jp2E6754faxkwLW6uEO4Pv42qb8qj4B8ZsIIxg0THhwfZyFVyK47nwOElG4E7CpUAAut69uqWcgmqA=\" rel=\"nofollow\" target=\"_blank\">renee@thrustsc.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZWE5MGM4NTYtNGNjOC00OTM0LWEwMWUtZjJmMzdiZWE1Y2Q5LTEyNzM4NDUtMjAyNi0wMi0wNS1lbg==\/tiny\/Boundless-Bio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) &#8212; Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026. The fireside chat session is scheduled for Thursday, February 12, in New York, NY, at 3:00 p.m. ET. A live and archived webcast of the session will be accessible under \u201cEvents &amp; Presentations\u201d in the Investors section of Boundless Bio\u2019s website. About Boundless Bio Boundless Bio\u00a0is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-934480","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) &#8212; Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026. The fireside chat session is scheduled for Thursday, February 12, in New York, NY, at 3:00 p.m. ET. A live and archived webcast of the session will be accessible under \u201cEvents &amp; Presentations\u201d in the Investors section of Boundless Bio\u2019s website. About Boundless Bio Boundless Bio\u00a0is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant &hellip; Continue reading &quot;Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-05T13:36:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026\",\"datePublished\":\"2026-02-05T13:36:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/\"},\"wordCount\":213,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/\",\"name\":\"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=\",\"datePublished\":\"2026-02-05T13:36:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","og_locale":"en_US","og_type":"article","og_title":"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026 - Market Newsdesk","og_description":"SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) &#8212; Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026. The fireside chat session is scheduled for Thursday, February 12, in New York, NY, at 3:00 p.m. ET. A live and archived webcast of the session will be accessible under \u201cEvents &amp; Presentations\u201d in the Investors section of Boundless Bio\u2019s website. About Boundless Bio Boundless Bio\u00a0is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant &hellip; Continue reading \"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-05T13:36:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026","datePublished":"2026-02-05T13:36:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/"},"wordCount":213,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/","name":"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=","datePublished":"2026-02-05T13:36:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0OTA1NyM3NDA5ODk4IzIyNjIyOTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/boundless-bio-to-participate-in-the-guggenheim-emerging-outlook-biotech-summit-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Boundless Bio to Participate in the\u00a0Guggenheim Emerging Outlook: Biotech Summit 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/934480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=934480"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/934480\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=934480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=934480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=934480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}